These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37991639)

  • 1. Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [
    Jussing E; Ferrat M; Moein MM; Alfredéen H; Tegnebratt T; Bratteby K; Samén E; Feldwisch J; Altena R; Axelsson R; Tran TA
    EJNMMI Radiopharm Chem; 2023 Nov; 8(1):41. PubMed ID: 37991639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic HER2-binding radiopharmaceutical, [
    Velikyan I; Schweighöfer P; Feldwisch J; Seemann J; Frejd FY; Lindman H; Sörensen J
    Am J Nucl Med Mol Imaging; 2019; 9(1):12-23. PubMed ID: 30911434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue.
    Tolmachev V; Velikyan I; Sandström M; Orlova A
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1356-67. PubMed ID: 20130858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Epidermal Growth Factor Receptor 2-Targeting [
    Alhuseinalkhudhur A; Lindman H; Liss P; Sundin T; Frejd FY; Hartman J; Iyer V; Feldwisch J; Lubberink M; Rönnlund C; Tolmachev V; Velikyan I; Sörensen J
    J Nucl Med; 2023 Sep; 64(9):1364-1370. PubMed ID: 37442602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT.
    Sörensen J; Velikyan I; Sandberg D; Wennborg A; Feldwisch J; Tolmachev V; Orlova A; Sandström M; Lubberink M; Olofsson H; Carlsson J; Lindman H
    Theranostics; 2016; 6(2):262-71. PubMed ID: 26877784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good manufacturing practice production of [(68)Ga]Ga-ABY-025 for HER2 specific breast cancer imaging.
    Velikyan I; Wennborg A; Feldwisch J; Lindman H; Carlsson J; Sörensen J
    Am J Nucl Med Mol Imaging; 2016; 6(2):135-53. PubMed ID: 27186441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer.
    Alhuseinalkhudhur A; Lubberink M; Lindman H; Tolmachev V; Frejd FY; Feldwisch J; Velikyan I; Sörensen J
    EJNMMI Res; 2020 Mar; 10(1):21. PubMed ID: 32201920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated synthesis of [
    Alfteimi A; Lützen U; Helm A; Jüptner M; Marx M; Zhao Y; Zuhayra M
    EJNMMI Radiopharm Chem; 2022 Jul; 7(1):20. PubMed ID: 35904684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the radiosynthesis of [68Ga]Ga-PSMA-11 using a Trasis MiniAiO synthesizer: do we need to heat and purify?
    Reverchon J; Khayi F; Roger M; Moreau A; Kryza D
    Nucl Med Commun; 2020 Sep; 41(9):977-985. PubMed ID: 32796487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients.
    Sandström M; Lindskog K; Velikyan I; Wennborg A; Feldwisch J; Sandberg D; Tolmachev V; Orlova A; Sörensen J; Carlsson J; Lindman H; Lubberink M
    J Nucl Med; 2016 Jun; 57(6):867-71. PubMed ID: 26912439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.
    Sandberg D; Tolmachev V; Velikyan I; Olofsson H; Wennborg A; Feldwisch J; Carlsson J; Lindman H; Sörensen J
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1337-1346. PubMed ID: 28261749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GMP production of [
    Velikyan I; Doverfjord JG; Estrada S; Steen H; Van Scharrenburg G; Antoni G
    Nucl Med Biol; 2020; 88-89():73-85. PubMed ID: 32805638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosynthesis of clinical doses of ⁶⁸Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based ⁶⁸Ge/⁶⁸Ga generators.
    Tworowska I; Ranganathan D; Thamake S; Delpassand E; Mojtahedi A; Schultz MK; Zhernosekov K; Marx S
    Nucl Med Biol; 2016 Jan; 43(1):19-26. PubMed ID: 26702783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated GMP-Compliant Production of [
    Wagner M; Doverfjord JG; Tillner J; Antoni G; Haack T; Bossart M; Laitinen I; Johansson L; Pierrou S; Eriksson O; Velikyan I
    Pharmaceuticals (Basel); 2020 Jul; 13(8):. PubMed ID: 32752075
    [No Abstract]   [Full Text] [Related]  

  • 15. [
    Jussing E; Lu L; Grafström J; Tegnebratt T; Arnberg F; Rosik HW; Wennborg A; Holmin S; Feldwisch J; Stone-Elander S
    EJNMMI Res; 2020 Sep; 10(1):106. PubMed ID: 32960353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment.
    Glaser M; Iveson P; Hoppmann S; Indrevoll B; Wilson A; Arukwe J; Danikas A; Bhalla R; Hiscock D
    J Nucl Med; 2013 Nov; 54(11):1981-8. PubMed ID: 24115530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold.
    Ahlgren S; Orlova A; Wållberg H; Hansson M; Sandström M; Lewsley R; Wennborg A; Abrahmsén L; Tolmachev V; Feldwisch J
    J Nucl Med; 2010 Jul; 51(7):1131-8. PubMed ID: 20554729
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.